U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 321

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
ChrMT:5782-13922
GRCh38:
ChrMT:5782-13922
Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemiaLikely pathogenic
(Nov 4, 2014)
criteria provided, single submitter
2.
GRCh37:
ChrMT:5794-14876
GRCh38:
ChrMT:5794-14876
Primary dilated cardiomyopathy, Macrocytic dyserythropoietic anemiaLikely pathogenic
(Nov 4, 2014)
criteria provided, single submitter
3.
GRCh37:
ChrMT:6468-15586
GRCh38:
ChrMT:6468-15586
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
4.
GRCh37:
ChrMT:7126-13988
GRCh38:
ChrMT:7126-13988
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
5.
GRCh37:
ChrMT:8290-13040
GRCh38:
ChrMT:8290-13040
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
6.
GRCh37:
ChrMT:8350-13450
GRCh38:
ChrMT:8350-13450
Pearson syndromePathogenic
(Jun 12, 2019)
no assertion criteria provided
7.
GRCh37:
ChrMT:8470-13446
GRCh38:
ChrMT:8470-13446
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
8.
GRCh37:
ChrMT:8480-13440
GRCh38:
ChrMT:8480-13440
Pearson syndromePathogenic
(Jun 12, 2019)
no assertion criteria provided
9.
GRCh37:
ChrMT:8585-12965
GRCh38:
ChrMT:8585-12965
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
10.
GRCh37:
ChrMT:8815-13722
GRCh38:
ChrMT:8815-13722
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
11.
GRCh37:
ChrMT:8839-14895
GRCh38:
ChrMT:8839-14895
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
12.
GRCh37:
ChrMT:10105-15066
GRCh38:
ChrMT:10105-15066
Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
13.
GRCh37:
ChrMT:10947-15537
GRCh38:
ChrMT:10947-15537
MT-TL2, MT-TS2, MT-CYB, MT-ND4, MT-ND5, MT-ND6, MT-TE, MT-THPearson syndromePathogeniccriteria provided, single submitter
14.
GRCh37:
ChrMT:11263-15374
GRCh38:
ChrMT:11263-15374
MT-ND6, MT-TE, MT-TH, MT-CYB, MT-ND4, MT-ND5, MT-TL2, MT-TS2Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
15.
GRCh37:
ChrMT:12114-14420
GRCh38:
ChrMT:12114-14420
MT-ND4, MT-ND5, MT-ND6, MT-TH, MT-TL2, MT-TS2Mitochondrial diseasePathogenic
(May 22, 2017)
no assertion criteria provided
16.
GRCh37:
ChrMT:12338
GRCh38:
ChrMT:12338
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
17.
GRCh37:
ChrMT:12340
GRCh38:
ChrMT:12340
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
18.
GRCh37:
ChrMT:12341
GRCh38:
ChrMT:12341
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
19.
GRCh37:
ChrMT:12344
GRCh38:
ChrMT:12344
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
20.
GRCh37:
ChrMT:12346
GRCh38:
ChrMT:12346
MT-ND5not provided, Leigh syndromeBenign/Likely benign
(Oct 17, 2019)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
ChrMT:12349
GRCh38:
ChrMT:12349
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
22.
GRCh37:
ChrMT:12352
GRCh38:
ChrMT:12352
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
23.
GRCh37:
ChrMT:12358
GRCh38:
ChrMT:12358
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
24.
GRCh37:
ChrMT:12361
GRCh38:
ChrMT:12361
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
25.
GRCh37:
ChrMT:12362
GRCh38:
ChrMT:12362
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
26.
GRCh37:
ChrMT:12367
GRCh38:
ChrMT:12367
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
27.
GRCh37:
ChrMT:12372
GRCh38:
ChrMT:12372
MT-ND5not specified, Mitochondrial diseaseConflicting interpretations of pathogenicity
(May 4, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
ChrMT:12373
GRCh38:
ChrMT:12373
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
29.
GRCh37:
ChrMT:12382
GRCh38:
ChrMT:12382
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
30.
GRCh37:
ChrMT:12383
GRCh38:
ChrMT:12383
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
31.
GRCh37:
ChrMT:12386
GRCh38:
ChrMT:12386
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
32.
GRCh37:
ChrMT:12389
GRCh38:
ChrMT:12389
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
33.
GRCh37:
ChrMT:12397
GRCh38:
ChrMT:12397
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
34.
GRCh37:
ChrMT:12400
GRCh38:
ChrMT:12400
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
35.
GRCh37:
ChrMT:12401
GRCh38:
ChrMT:12401
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
36.
GRCh37:
ChrMT:12403
GRCh38:
ChrMT:12403
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
37.
GRCh37:
ChrMT:12406
GRCh38:
ChrMT:12406
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
38.
GRCh37:
ChrMT:12410
GRCh38:
ChrMT:12410
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
39.
GRCh37:
ChrMT:12418
GRCh38:
ChrMT:12418
MT-ND5Mitochondrial myopathy with reversible cytochrome C oxidase deficiency, Leber optic atrophy, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke
Pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
ChrMT:12424
GRCh38:
ChrMT:12424
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
41.
GRCh37:
ChrMT:12425
GRCh38:
ChrMT:12425
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
42.
GRCh37:
ChrMT:12426
GRCh38:
ChrMT:12426
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
43.
GRCh37:
ChrMT:12432
GRCh38:
ChrMT:12432
MT-ND5not providedUncertain significance
(Dec 22, 2015)
criteria provided, single submitter
44.
GRCh37:
ChrMT:12436
GRCh38:
ChrMT:12436
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
45.
GRCh37:
ChrMT:12437
GRCh38:
ChrMT:12437
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
46.
GRCh37:
ChrMT:12448
GRCh38:
ChrMT:12448
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
47.
GRCh37:
ChrMT:12448
GRCh38:
ChrMT:12448
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
48.
GRCh37:
ChrMT:12451
GRCh38:
ChrMT:12451
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
49.
GRCh37:
ChrMT:12454
GRCh38:
ChrMT:12454
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
50.
GRCh37:
ChrMT:12457
GRCh38:
ChrMT:12457
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
51.
GRCh37:
ChrMT:12458
GRCh38:
ChrMT:12458
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
52.
GRCh37:
ChrMT:12479
GRCh38:
ChrMT:12479
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
53.
GRCh37:
ChrMT:12481
GRCh38:
ChrMT:12481
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
54.
GRCh37:
ChrMT:12481
GRCh38:
ChrMT:12481
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
55.
GRCh37:
ChrMT:12490
GRCh38:
ChrMT:12490
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
56.
GRCh37:
ChrMT:12493
GRCh38:
ChrMT:12493
MT-ND5not providedUncertain significance
(Apr 11, 2017)
criteria provided, single submitter
57.
GRCh37:
ChrMT:12499
GRCh38:
ChrMT:12499
MT-ND5not providednot providedno assertion provided
58.
GRCh37:
ChrMT:12501
GRCh38:
ChrMT:12501
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
59.
GRCh37:
ChrMT:12509
GRCh38:
ChrMT:12509
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
60.
GRCh37:
ChrMT:12512
GRCh38:
ChrMT:12512
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
61.
GRCh37:
ChrMT:12520
GRCh38:
ChrMT:12520
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
62.
GRCh37:
ChrMT:12530
GRCh38:
ChrMT:12530
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
63.
GRCh37:
ChrMT:12535
GRCh38:
ChrMT:12535
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
64.
GRCh37:
ChrMT:12542
GRCh38:
ChrMT:12542
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
65.
GRCh37:
ChrMT:12544
GRCh38:
ChrMT:12544
MT-ND5Mitochondrial diseaseUncertain significance
(Dec 10, 2021)
reviewed by expert panel
FDA Recognized Database
66.
GRCh37:
ChrMT:12545
GRCh38:
ChrMT:12545
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
67.
GRCh37:
ChrMT:12556
GRCh38:
ChrMT:12556
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
68.
GRCh37:
ChrMT:12557
GRCh38:
ChrMT:12557
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
69.
GRCh37:
ChrMT:12560
GRCh38:
ChrMT:12560
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
70.
GRCh37:
ChrMT:12561
GRCh38:
ChrMT:12561
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
71.
GRCh37:
ChrMT:12587
GRCh38:
ChrMT:12587
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
72.
GRCh37:
ChrMT:12599
GRCh38:
ChrMT:12599
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
73.
GRCh37:
ChrMT:12601
GRCh38:
ChrMT:12601
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
74.
GRCh37:
ChrMT:12613
GRCh38:
ChrMT:12613
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
75.
GRCh37:
ChrMT:12622
GRCh38:
ChrMT:12622
MT-ND5Leigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
76.
GRCh37:
ChrMT:12631
GRCh38:
ChrMT:12631
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
77.
GRCh37:
ChrMT:12634
GRCh38:
ChrMT:12634
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
78.
GRCh37:
ChrMT:12661
GRCh38:
ChrMT:12661
MT-ND5N109YLeigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
79.
GRCh37:
ChrMT:12662
GRCh38:
ChrMT:12662
MT-ND5N109SLeigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
80.
GRCh37:
ChrMT:12673
GRCh38:
ChrMT:12673
MT-ND5N113DLeigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
81.
GRCh37:
ChrMT:12674
GRCh38:
ChrMT:12674
MT-ND5N113SLeigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
82.
GRCh37:
ChrMT:12681
GRCh38:
ChrMT:12681
MT-ND5not providedLikely benign
(Aug 12, 2015)
criteria provided, single submitter
83.
GRCh37:
ChrMT:12706
GRCh38:
ChrMT:12706
MT-ND5F124LMitochondrial diseaseLikely pathogenic
(Jun 30, 2022)
reviewed by expert panel
FDA Recognized Database
84.
GRCh37:
ChrMT:12713
GRCh38:
ChrMT:12713
MT-ND5I126TLeigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
85.
GRCh37:
ChrMT:12715
GRCh38:
ChrMT:12715
MT-ND5T127ALeigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
86.
GRCh37:
ChrMT:12730
GRCh38:
ChrMT:12730
MT-ND5V132ILeigh syndromeLikely benign
(Oct 17, 2019)
criteria provided, single submitter
87.
GRCh37:
ChrMT:12743
GRCh38:
ChrMT:12743
MT-ND5N136SLeigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
88.
GRCh37:
ChrMT:12757
GRCh38:
ChrMT:12757
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
89.
GRCh37:
ChrMT:12770
GRCh38:
ChrMT:12770
MT-ND5Juvenile myopathy, encephalopathy, lactic acidosis AND strokePathogenic
(Jan 1, 2003)
no assertion criteria provided
90.
GRCh37:
ChrMT:12775
GRCh38:
ChrMT:12775
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
91.
GRCh37:
ChrMT:12797
GRCh38:
ChrMT:12797
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
92.
GRCh37:
ChrMT:12799
GRCh38:
ChrMT:12799
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
93.
GRCh37:
ChrMT:12810
GRCh38:
ChrMT:12810
MT-ND5not providedLikely benign
(Aug 12, 2015)
criteria provided, single submitter
94.
GRCh37:
ChrMT:12811
GRCh38:
ChrMT:12811
MT-ND5Mitochondrial diseaseBenign
(Apr 17, 2023)
reviewed by expert panel
FDA Recognized Database
95.
GRCh37:
ChrMT:12814
GRCh38:
ChrMT:12814
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
96.
GRCh37:
ChrMT:12820
GRCh38:
ChrMT:12820
MT-ND5Leigh syndromeBenign
(Oct 17, 2019)
criteria provided, single submitter
97.
GRCh37:
ChrMT:12835
GRCh38:
ChrMT:12835
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
98.
GRCh37:
ChrMT:12836
GRCh38:
ChrMT:12836
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
99.
GRCh37:
ChrMT:12842
GRCh38:
ChrMT:12842
MT-ND5Leigh syndromeUncertain significance
(Oct 17, 2019)
criteria provided, single submitter
100.
GRCh37:
ChrMT:12848
GRCh38:
ChrMT:12848
MT-ND5Leber optic atrophyPathogenic
(Nov 1, 2005)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination